Effect of Intranasal Insulin on POCD and POD
Does Intranasal Insulin Administration Reduce the Incidence of Cognitive Dysfunction After Cardiac Surgery?
Sponsor: Hiroaki Sato, MD., PhD.
Listed as NCT03415061, this NA trial focuses on Delirium and Heart Diseases and remains ongoing. Sponsored by Hiroaki Sato, MD., PhD., it has been updated 10 times since 2021, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Nov 2021 — Jul 2024 [monthly]
Not Yet Recruiting NA
Status: Active Not Recruiting → Not Yet Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2019 — Oct 2020 [monthly]
Recruiting NA
-
Apr 2019 — Oct 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hiroaki Sato, MD., PhD.
For direct contact, visit the study record on ClinicalTrials.gov .